The global Aspiration and Biopsy Needles Market according to the most recent analysis by Emergen Research, size was USD 875.3 Million in 2021 and is anticipated to see a revenue CAGR of 6.8% over the projection period. The most prevalent cancers are breast cancer, lung cancer, thyroid cancer, prostate cancer, colon and rectum cancer, liver cancer, kidney cancer, leukaemia, pancreatic cancer, and bladder cancer, according to the National Cancer Institute (NCI), the U.S. government's primary agency for cancer research. While breast, colorectal, and lung cancers are anticipated to account for approximately 50% of all newly diagnosed instances of cancer in women in 2020, prostate, colorectal, and lung cancers currently account for approximately 43% of all cancer cases in men.
The preference for minimally invasive procedures over open and closed surgical biopsies is one of the key factors anticipated to fuel market expansion. Aspiration and biopsy needle demand is increasing, especially in densely populated and developing nations, due to the ability to provide a quicker, more accurate, and more reliable identification of malignancies in a resource-constrained scenario with a low requirement of instruments.
https://www.emergenresearch.com/industry-report/aspiration-and-biopsy-needles-market
The global Aspiration and Biopsy Needles Market according to the most recent analysis by Emergen Research, size was USD 875.3 Million in 2021 and is anticipated to see a revenue CAGR of 6.8% over the projection period. The most prevalent cancers are breast cancer, lung cancer, thyroid cancer, prostate cancer, colon and rectum cancer, liver cancer, kidney cancer, leukaemia, pancreatic cancer, and bladder cancer, according to the National Cancer Institute (NCI), the U.S. government's primary agency for cancer research. While breast, colorectal, and lung cancers are anticipated to account for approximately 50% of all newly diagnosed instances of cancer in women in 2020, prostate, colorectal, and lung cancers currently account for approximately 43% of all cancer cases in men. The preference for minimally invasive procedures over open and closed surgical biopsies is one of the key factors anticipated to fuel market expansion. Aspiration and biopsy needle demand is increasing, especially in densely populated and developing nations, due to the ability to provide a quicker, more accurate, and more reliable identification of malignancies in a resource-constrained scenario with a low requirement of instruments. https://www.emergenresearch.com/industry-report/aspiration-and-biopsy-needles-market
Aspiration & Biopsy Needles Market Trend | Industry Forecast by 2030
The global Aspiration & Biopsy Needles market size reached USD 875.3 Million in 2021 and is expected to reach USD 1584.8 Million in 2030 registering a CAGR of 6.8%. Aspiration & Biopsy Needles industry report classifies global market by share, trend, growth and based on product, procedures, application, and region.
0 Comments 0 Shares